Lab diag. tb
-
Upload
deepak-deshkar -
Category
Education
-
view
3.293 -
download
14
Transcript of Lab diag. tb
11
Hi ! Good Morning ! I am Hi ! Good Morning ! I am Mycobacterium Mycobacterium
tuberculosis.tuberculosis.
22
LABORATORY DIAGNOSIS LABORATORY DIAGNOSIS OF OF
MYCOBACTERIUM MYCOBACTERIUM TUBERCULOSISTUBERCULOSIS
33
NEED FOR ACCURATE & EARLY NEED FOR ACCURATE & EARLY DIAGNOSIS OF TUBERCULOSIS.DIAGNOSIS OF TUBERCULOSIS.
• Tuberculosis mainly Tuberculosis mainly caused by M.tuberculosis.caused by M.tuberculosis.
• Is a major health problem Is a major health problem world wide.world wide.
• Found in Neolithic Found in Neolithic remains.remains.
• Largest cause of Largest cause of “DEATHS” from a “DEATHS” from a single infectious single infectious disease.disease.
• HENCE “ACCURATE” & HENCE “ACCURATE” & “EARLY” diagnosis is “EARLY” diagnosis is required for its required for its effective effective “MANAGEMENT”.“MANAGEMENT”.
44
LABORATORY DIAGNOSIS MAY LABORATORY DIAGNOSIS MAY BE ESTABLISHED BY:BE ESTABLISHED BY:
• Demonstration of bacillus by Demonstration of bacillus by microscopy.microscopy.
• Isolation in culture.Isolation in culture.• Transmitting the infection in Transmitting the infection in
experimental animals.experimental animals.• Demonstration of hypersensitivity to Demonstration of hypersensitivity to
tuberculoprotein – Mantoux test.tuberculoprotein – Mantoux test.• Enzyme linked Immunosorbent Spot Enzyme linked Immunosorbent Spot
(ELISPOT) Assay.(ELISPOT) Assay.
55
LABORATORY DIAGNOSIS LABORATORY DIAGNOSIS CONTD.CONTD.• QuantiFeron TB Gold QuantiFeron TB Gold
Test.Test.
• ELISA to detect 38 KDA ELISA to detect 38 KDA Mycobacterial Antigen.Mycobacterial Antigen.
• Molecular methods for Molecular methods for early diagnosis.early diagnosis.
* Amplicor test* Amplicor test * E – MTD* E – MTD * DNA sequencing* DNA sequencing * Line Probe Assay (LiPA)* Line Probe Assay (LiPA) * DNA micro arrays* DNA micro arrays * Molecular beacons.* Molecular beacons. * Single strand conformation * Single strand conformation
Polymorphism (SSCP)Polymorphism (SSCP) * FRET Probes.* FRET Probes.
• Other PCR based Other PCR based Techniques.Techniques.
* Amplification Mutation* Amplification Mutation
{ ARMS }{ ARMS }
* Branch Migration Inhibition* Branch Migration Inhibition
{ BMI }{ BMI }
• Ligase Chain Reaction.Ligase Chain Reaction.
• Diagnosis of TB & Drug Diagnosis of TB & Drug Resistant TB with Resistant TB with Mycobacteriophages.Mycobacteriophages.
66
SPECIMENS COLLECTEDSPECIMENS COLLECTED• Pulmonary secretions – Pulmonary secretions – ** spontaneously produced or induced sputum** spontaneously produced or induced sputum
** gastric lavage** gastric lavage
** transtracheal aspiration** transtracheal aspiration
** bronchoscopy** bronchoscopy
** laryngeal swabbing** laryngeal swabbing
• Gastric lavage specimens.Gastric lavage specimens.
• Urine samples.Urine samples.
• Faecal specimens.Faecal specimens.
• Tissue & Body Fluid specimens.Tissue & Body Fluid specimens.
• Blood specimensBlood specimens
• Wound ,skin lesion aspirates.Wound ,skin lesion aspirates.
• Cervical swab.Cervical swab.
77
SPUTUM EXAMINED BY :SPUTUM EXAMINED BY :
• DIRECT METHOD DIRECT METHOD # Z.N.Staining.# Z.N.Staining.
# Fluorescent Auramine Rhodamine staining# Fluorescent Auramine Rhodamine staining
• AFTER CONCENTRATION AFTER CONCENTRATION
88
Acid-fast bacilliAcid-fast bacilli
99
ZN Smear evaluation & AFB ZN Smear evaluation & AFB ReportReport
(Grading of smear)(Grading of smear)No. of AFBNo. of AFB No. of OIFNo. of OIF ReportReport
00 300300 AFB Not seenAFB Not seen
01 – 0201 – 02 300300 Doubtful; Doubtful; Repeat smearRepeat smear
01 – 0901 – 09 100100 1+1+
01 – 0901 – 09 1010 2+2+
01 – 09 01 – 09 0101 3+3+
10 or more10 or more 0101 4+4+
1010
Indications for Culture Indications for Culture
• Failures of re-treatment casesFailures of re-treatment cases
• Seriously ill cases;Seriously ill cases;– extra-pulmonary casesextra-pulmonary cases – smear negative cases smear negative cases – childhood TB & HIV-TBchildhood TB & HIV-TB
• For DRSFor DRS
• Not for New Smear Positive CasesNot for New Smear Positive Cases
1111
Decontamination ProceduresDecontamination Procedures1946 – Trisodium Phosphate 1946 – Trisodium Phosphate
1955 – Pancreatin Desogen 1955 – Pancreatin Desogen
1958 – Pancreatin + 1% cetrimide1958 – Pancreatin + 1% cetrimide
1915 – Petroff’s NaOH 1915 – Petroff’s NaOH
1962 – Zephiran Trisodium PO1962 – Zephiran Trisodium PO44
1963 – N-acetyl L- cysteine + 2%NaOH1963 – N-acetyl L- cysteine + 2%NaOH
1969 – Swab culture technique + 1% cetrimide1969 – Swab culture technique + 1% cetrimide
1975 – CPC + NaCl1975 – CPC + NaCl22
1212
PETROFF’S METHODPETROFF’S METHOD
Advantages:Advantages:Simple, inexpensive & control the growth of Simple, inexpensive & control the growth of
contaminantscontaminantsTwenty samples can be processed in 2 Hrs, with Twenty samples can be processed in 2 Hrs, with
centrifuge capacity being the limiting factorcentrifuge capacity being the limiting factorSterilized NaOH can be kept for several weeksSterilized NaOH can be kept for several weeks
Limitations:Limitations:The specimen exposure times must be strictly The specimen exposure times must be strictly
followed to prevent over kill of tubercle bacilli. followed to prevent over kill of tubercle bacilli. The initial kill is independent of additional The initial kill is independent of additional contributory factors such as heat build-up in the contributory factors such as heat build-up in the centrifuge and centrifugal efficiencycentrifuge and centrifugal efficiency
1313
Processing of sputum with CPC Processing of sputum with CPC MethodMethod
If delay of more than 48 hours If delay of more than 48 hours between collection and processing is between collection and processing is anticipated, the sputum should be anticipated, the sputum should be collected with 1%CPC and 2%NaCl2collected with 1%CPC and 2%NaCl2
CPC acts as homogenizing and CPC acts as homogenizing and decontaminating agent decontaminating agent
It helps in retaining viability of It helps in retaining viability of Tubercle bacilli up to 7 daysTubercle bacilli up to 7 days
These specimens should not be These specimens should not be treated with NaOH ( Petroff’s)treated with NaOH ( Petroff’s)
1414
MYCOBACTERIAL CULTUREMYCOBACTERIAL CULTUREAdvantagesAdvantages::
Increases number of cases foundIncreases number of cases foundDetects cases among smear negative patientsDetects cases among smear negative patientsEstablishes viability of organismsEstablishes viability of organismsDistinguishing between Mycobacterial speciesDistinguishing between Mycobacterial speciesHelps in performing DSTHelps in performing DSTHelps in diagnosing cases of failureHelps in diagnosing cases of failure
LimitationsLimitations::
Expensive Expensive Require enriched mediaRequire enriched mediaRequire considerable expertise Require considerable expertise Time consumingTime consuming
1515
Specimen
Sterile Non - Sterile
Centrifuge & use sediment Liquefaction (N-acetyl-L- cystein)
Decontamination NaOH
Neutralization Buffer or H2O
Centrifugation > 3000 X g
Screen by AFB smear & inoculate media (one liquid & one solid)
FLOW CHART OF SPECIMEN PROCESSING FOR ISOLATION OF MYCOBACTERIA
1616
FLOW CHART CONTD.
Screen by AFB smear & inoculate media (one liquid & one solid)
Liquid Medium Solid Media
MGIT BACTEC SEPTI-CHEK
CMS
IncubateAt 37ºCFor 6 wks
IncubateAt 37ºCFor 6 wks
IncubateinvertingAt 37ºCFor 8 wks
IncubateAt 37ºCFor 6 wks
Fluoresc--ence detected
GrowthIndex>10
Colonies orturbidity
Growthdetected
Confirm by AFB smear Reinoculate onSolid media
L J
L J with RNA
LJ with Pyruvic acid
Incubate
At 37ºCFor 8 wks
If growthConfirm onAFB smear
1717
Reading and ReportingReading and Reporting
Characteristics of Tubercle bacilliCharacteristics of Tubercle bacilliGrowth of Primary culture takes 2 – 4 Growth of Primary culture takes 2 – 4
weeks to obtain visible coloniesweeks to obtain visible coloniesColonies are buff colored and rough, Colonies are buff colored and rough,
having the appearance of bread crumbs or having the appearance of bread crumbs or cauliflowercauliflower
Not easily emulsified but give a granular Not easily emulsified but give a granular suspensionsuspension
Microscopically frequently arranged in Microscopically frequently arranged in serpentine cords of varying length or serpentine cords of varying length or show linear clumpingshow linear clumping
1818
Culture Media : SolidCulture Media : Solid
LJLJ
LJ with Na pyruvateLJ with Na pyruvate
LJ with out asparagineLJ with out asparagine
Middlebrook’s 7H10 & 7H11Middlebrook’s 7H10 & 7H11
Selective 7H10 & 11Selective 7H10 & 11
Ogawa Ogawa
Tarshi’s Blood AgarTarshi’s Blood Agar
1919
Slow growthSlow growth
3-4 wk
2020
24-hr generation time24-hr generation time
AFB
AFB
AFB
24 hr
2121
MYCOBACTERIAL COLONIES ON SOLID MYCOBACTERIAL COLONIES ON SOLID MEDIAMEDIA
2222
Colonies growing on mediaColonies growing on media
2323
Laboratory diagnosisLaboratory diagnosis
• Traditional (slow)Traditional (slow)– Growth on solid mediaGrowth on solid media– Biochemical tests to speciateBiochemical tests to speciate
• RecentRecent– Radiometric growth detectionRadiometric growth detection– BACTECBACTEC– SEPTI – CHEKSEPTI – CHEK– MGITMGIT– Gene probes to speciateGene probes to speciate
2424
Flow ChartFlow ChartIdentification of Tubercle bacilli & Identification of Tubercle bacilli &
relatedrelatedGrowth on LJ Medium
Rapid growth within 7 daysGrowth on MacConkey Agar
Aryl-sulphataes test
Slow GrowthNiacin test
-VeTellurite
Reduction
+ veM. smegmatis
- veM. phlei
- veType of growth
+ veM.
tuberculosis+ ve
M. Fortuitumcomplex
Pigment Scanty Smooth Flat Colonies
In LightGroup I
Photochromogens
In DarkGroup II
Scotochromogens
No PigmentGroup III
Non - Chromogens
- veBCG
+ veM. bovis
M.KansasiM.intermedium
M.SzulgaiM.scrofulaceum
M.Avium complexM.gastri
2525
Other Culture MethodsOther Culture Methods
• Septi-check AFBSepti-check AFB
• MGIT 960MGIT 960
• Backtec/MB/BactBacktec/MB/Bact
• ESP Culture iiESP Culture ii
• MMicroscopic icroscopic OObservation of bservation of BBroth roth CCulture ulture
• MODS: MMODS: Micro icro CColony olony DDetection etection SSystemystem
2626
BACTEC CONTINUOUS MONITORING BACTEC CONTINUOUS MONITORING SYSTEMSYSTEM
2727
BLOOD CULTURE BOTTLES FOR BLOOD CULTURE BOTTLES FOR BACTEC 9240,9120,9050.BACTEC 9240,9120,9050.
2828
SEPTI - CHECKSEPTI - CHECK
2929
Radiolabeled palmitic acidRadiolabeled palmitic acid
AFB*C___
*C___ *C___
*C___
3030
Detect growth with CODetect growth with CO22
AFBAFB
AFBAFB
AFB
*CO2
*CO2
*C___
*C___
3131
BIOCHEMICAL REACTIONS:BIOCHEMICAL REACTIONS:
SPECIES NIACIN TEST
ARYL-SULPH---ATASE TEST
NITRATE REDUC---TION TEST
HOT CATAL---ASE TEST
PEROX---IDASE TEST
TWEEN 80
HYDRO--LYSIS TSET
TELLURI--TE REDUCTION TEST
GROWTH ON TCH
PYRAZI-NAMIDASE TSET
UREASE TEST
M tuberculosis
+ - + - + - +/- + + +
M bovis
- - - - - - +/- - - +
M African
um
- - - - - - - +/- - +
3232
BIOCHEMICAL REACTIONSBIOCHEMICAL REACTIONS
3333
BIOCHEMICAL REACTIONSBIOCHEMICAL REACTIONS
3434
BIOCHEMICAL REACTIONSBIOCHEMICAL REACTIONS
3535
BIOCHEMICAL REACTIONSBIOCHEMICAL REACTIONS
3636
ANIMAL INOCULATIONANIMAL INOCULATION
• Intramuscular injection of the bacterial Intramuscular injection of the bacterial
concentrated material into two healthy concentrated material into two healthy
guinea pigs of 12 week and autopsied, guinea pigs of 12 week and autopsied,
one after four weeks & second after one after four weeks & second after eight eight
weeks of inoculation.weeks of inoculation.
3737
ANTIGEN PROTEIN DETECTIONANTIGEN PROTEIN DETECTION• Tuberculostearic acid :Tuberculostearic acid : a fatty extracted from a fatty extracted from
the cell wall of M.tuberculosis detected by gas the cell wall of M.tuberculosis detected by gas
chromatography/ mass spectrometry in clinical chromatography/ mass spectrometry in clinical
samples. samples. M.tuberculosis is unique to release M.tuberculosis is unique to release
tuberculostearic acid .tuberculostearic acid .
• Host enzyme Adenosine deaminase :Host enzyme Adenosine deaminase : Host Host
enzyme. It is increased in infection caused by enzyme. It is increased in infection caused by
M.tuberculosis.M.tuberculosis.
3838
CHROMATOGRAPHIC ANALYSISCHROMATOGRAPHIC ANALYSIS
Analysis of mycobacterial lipids by ----Analysis of mycobacterial lipids by ---- * Thin paper chromatography* Thin paper chromatography * Gas liquid chromatography (GLC)* Gas liquid chromatography (GLC) * Reverse phase high performance liquid chromatography * Reverse phase high performance liquid chromatography
( HPLC)( HPLC)
HPLC of extracted mycobacteria -HPLC of extracted mycobacteria -
* A very rapid & specific method for identification of species.* A very rapid & specific method for identification of species.
3939
Why Measure Interferon-Why Measure Interferon-??
• TB infection induces T-cell response (CMI)TB infection induces T-cell response (CMI)• IFN- IFN- is the ‘classic’ CMI cytokine is the ‘classic’ CMI cytokine• Produced Produced in vitroin vitro in response to specific in response to specific
antigenantigen• Secreted in measurable and stable Secreted in measurable and stable
amountsamounts• Absent from normal circulationAbsent from normal circulation• Extensive literature showing importance Extensive literature showing importance
of IFN-of IFN- in TB infection in TB infection
4040
What is Quanti-FERONWhat is Quanti-FERON®®-TB -TB GoldGold
•Blood assay for Blood assay for M. tuberculosis > M. tuberculosis > Interferon Interferon γγ release assay release assay
•In vitroIn vitro test using whole blood test using whole blood specimen for the diagnosis of TB specimen for the diagnosis of TB infection, whether latent or activeinfection, whether latent or active
•Does not distinguish between latent TB Does not distinguish between latent TB infection or TB diseaseinfection or TB disease
4141
Quanti-FERONQuanti-FERON®®-TB Gold – -TB Gold – Scientific BasisScientific Basis
•This recognition process involves the This recognition process involves the generation of interferon-generation of interferon-γγ, a specific cytokine , a specific cytokine for cell mediated immune responsefor cell mediated immune response
•Individuals infected with Individuals infected with M. tuberculosisM. tuberculosis complex organisms have lymphocytes in their complex organisms have lymphocytes in their blood that recognize mycobacterial antigensblood that recognize mycobacterial antigens
•The detection and subsequent quantification The detection and subsequent quantification of IFN-of IFN-γγ is the basis of this test is the basis of this test
•The test uses synthetic peptide antigens The test uses synthetic peptide antigens (ESAT-6, CFP-10) that simulate mycobacterial (ESAT-6, CFP-10) that simulate mycobacterial proteins to generate the immune responseproteins to generate the immune response
4242
Interferon Gamma ReleaseInterferon Gamma Release
4343
Whole Blood IFN-Whole Blood IFN- Assay AssayQuantiFERON-TB TestQuantiFERON-TB Test
ESAT-6 CFP 10MitogenControl
TMBTMB
COLORCOLOR
Stage 1 Whole Blood CultureStage 1 Whole Blood Culture
Stage 2 IFN-gamma ELISAStage 2 IFN-gamma ELISA
NilControl
Incubate Incubate →→ INF- INF- from sensitized T-from sensitized T-
cellscells
Draw blood Draw blood + heparin+ heparin
Aliquot blood Aliquot blood & add antigen& add antigen
Harvest plasma Harvest plasma from above settled from above settled
cellscells
Measure [ IFN-Measure [ IFN-] in ] in ‘Sandwich’ ELISA‘Sandwich’ ELISA
ComputerizedComputerizedinterpretationinterpretation
Cellestis
4444
Species Specificity of ESAT-6 and Species Specificity of ESAT-6 and CFP-10CFP-10
4545
QFT AssayQFT Assay
4646
In VivoIn Vivo and and In VitroIn Vitro Diagnostic TestsDiagnostic Tests
Antigenpresenting
cell
MemoryT-cell
Presentation ofmycobacterial antigens
IFN-
IFN-
IL-8, etc.
IL-8, etc.
TNF-
TNF-
4747
Results and InterpretationResults and InterpretationRESULTRESULT INTERPRETATIONINTERPRETATION
POSITIVEPOSITIVE ESAT-6 and/or CFP-10 ESAT-6 and/or CFP-10 responsiveness detectedresponsiveness detected
M. tuberculosisM. tuberculosis infection infection likelylikely
NEGATIVENEGATIVE No ESAT-6 or CFP-10 No ESAT-6 or CFP-10 responsiveness detectedresponsiveness detected
M. tuberculosis M. tuberculosis unlikelyunlikely
INDETERMINATEINDETERMINATE MTB infection status cannot MTB infection status cannot be determined as a result of be determined as a result of impaired immunity and/or impaired immunity and/or incorrect performance of incorrect performance of the testthe test
4848
QFT and TSTQFT and TSTQFTQFT
•in vitroin vitro test test
•Specific antigensSpecific antigens
•No boostingNo boosting
•1 patient visit1 patient visit
•Lab variabilityLab variability
•Results possible in 1 Results possible in 1 dayday
•Requires phlebotomyRequires phlebotomy
•Includes + controlIncludes + control
TSTTST
•in vivoin vivo test test
•Less specific PPDLess specific PPD
•BoostingBoosting
•2 patient visits2 patient visits
•Inter-reader variabilityInter-reader variability
•Results in 2-3 daysResults in 2-3 days
•No phlebotomy No phlebotomy requiredrequired
•No + controlNo + control
4949
T-Spot.T-Spot.TBTB: : “Six“Six easy Steps”easy Steps”
Nil Control
Positive Control
Infection
Infection
Oxford Immunotec
5050
ENZYME LINKED IMMUNOSORBENTENZYME LINKED IMMUNOSORBENT SPOT (ELISPOT) TEST.SPOT (ELISPOT) TEST.
• It is based on ELISA testIt is based on ELISA test
• Allows visualization of secretory Allows visualization of secretory products of individual activated cells.products of individual activated cells.
• Provides information about type of Provides information about type of immune protein (qualitative)& immune protein (qualitative)& number of responding cells number of responding cells (quantitative)(quantitative)
5151
USING ELISA TO DETECT USING ELISA TO DETECT 38kDA MYCOBACTERIAL 38kDA MYCOBACTERIAL
ANTIGENANTIGEN• 38 kDA secretory protein being one of 38 kDA secretory protein being one of the the
most important specific antigens of MTBmost important specific antigens of MTB
• It induses B & T cell responses with high It induses B & T cell responses with high
specificity to MTBspecificity to MTB
• Detected by Direct & Sandwich ELISA.Detected by Direct & Sandwich ELISA.
5252
Mantoux Tuberculin Skin Test
•Preferred method of testing for TB infection in adults and children
•Tuberculin skin testing useful for
- Examining person who is not ill but may be infected
- Determining how many people in group are infected
- Examining person who has symptoms of TB
5353
Administering the Tuberculin Skin Test
•Inject intradermally 0.1 ml of 5TU PPD tuberculin
•Produce wheal 6 mm to 10 mm in diameter
•Do not recap, bend, or breakneedles, or remove needles from syringes
•Follow universal precautions for infection control
5454
Reading the Tuberculin Skin Test
•Read reaction 48-72Hours after injection
•Measure only induration
•Record reaction inmillimeters
5555
Classifying the Tuberculin Reaction
>5 mm is classified as positive in
• HIV-positive persons
• Recent contacts of TB case • Persons with fibrotic changes on chest
radiograph consistent with old healed TB
• Patients with organ transplants and other immunosuppressed patients
5656
Classifying the Tuberculin Reaction (cont.)
>10 mm is classified as positive in• Recent arrivals from high-prevalence countries
• Injection drug users
• Residents and employees of high-risk congregate settings
• Mycobacteriology laboratory personnel
• Persons with clinical conditions that place them at high risk
• Children <4 years of age, or children and adolescentsexposed to adults in high-risk categories
5757
Classifying the Tuberculin Reaction (cont.)
>15 mm is classified as positive in
• Persons with no known risk factors for TB
• Targeted skin testing programs should only be conducted among high-risk groups
5858
BCG and TST (1)BCG and TST (1)• General teaching is that reactivity from General teaching is that reactivity from
BCG wanes after a few years and is BCG wanes after a few years and is unlikely to persist > 10 years, but may be unlikely to persist > 10 years, but may be boosted by PPD.boosted by PPD.
• Study done in Switzerland* suggests that Study done in Switzerland* suggests that false positives due to BCG may be much false positives due to BCG may be much more common than we thought:more common than we thought:– 40% of 5000 HCW had positive TST40% of 5000 HCW had positive TST– Prior BCG strongest risk factor for positive TST Prior BCG strongest risk factor for positive TST
among those less than age 40 with TSTs among those less than age 40 with TSTs <<18 18 mm (was not as strong a risk factor for those mm (was not as strong a risk factor for those > 40 years old and those with TSTs > 40 years old and those with TSTs >> 20 mm) 20 mm)
5959
BCG and TST (2)BCG and TST (2)
• Review of studies that compared TST Review of studies that compared TST responses to BCG during and after infancyresponses to BCG during and after infancy
• Vaccination during infancy estimated to Vaccination during infancy estimated to cause false-positive TST in 6.3% overall, cause false-positive TST in 6.3% overall, but only 1% of those tested more than 10 but only 1% of those tested more than 10 years after vaccinationyears after vaccination
• Vaccination at 2 years of age or older Vaccination at 2 years of age or older estimated to cause false-positive TST in estimated to cause false-positive TST in 40% of persons overall, 20% of those 40% of persons overall, 20% of those tested 10 years or more after vaccinationtested 10 years or more after vaccination
Farhat M et al, Int J Tuberc Lung Dis 2006; 10: 1192-204
6060
Nucleic acid amplification Nucleic acid amplification for mycobact. diagnosisfor mycobact. diagnosis
Genus specific protocolsTargeting genes code for 16S rRNA
65KDa hsp M.TB Complex specific is 6110Other targets: Genes encoding 38 KDa MPB 64 mtp 40 PMT 64Methods:Target amplification - PCR(TMA, LCR, SDA or signal amplification EG: QB amplification)
PFYFFER G.E. J.INF. 1999, 39, 21-26. TC/ICM 30
6161
MOLECULAR TECHNIQUES TO MOLECULAR TECHNIQUES TO DETECT M.TUBERCULOSIS - 1DETECT M.TUBERCULOSIS - 1
•Amplicor TestAmplicor Test
** Detects the presence of the ** Detects the presence of the
mycobacterial 16S ribosomal mycobacterial 16S ribosomal ( rRNA)( rRNA)
gene by the PCR amplification gene by the PCR amplification
followed by ELISA reaction.followed by ELISA reaction.
6262
Mycobacteria (AFB) sampleMycobacteria (AFB) sample
AFB
6363
Extract 16S RNAExtract 16S RNA
16SRNA
6464
Probe for specific 16S RNAProbe for specific 16S RNA
16SRNA
ProbeProbe
6565
Probe remains in sampleProbe remains in sample
16SRNA
Probe
6666
Detector binds to probeDetector binds to probe
16SRNA
Probe**************
6767
Detector remains in sampleDetector remains in sample
16SRNA
Probe*******
6868
Detector identifies 16S RNADetector identifies 16S RNA
16SRNA
Probe*******
6969
MOLECULAR TECHNIQUES TO MOLECULAR TECHNIQUES TO DETECT M.TUBERCULOSIS - 2DETECT M.TUBERCULOSIS - 2
•E – MTDE – MTD ** The assay is based on the
transcription mediated amplification system ( TMA ).The mycobacterial rRNA from target cells is released by sonication & amplified a billion fold by TMA.
7070
Conventional method for Conventional method for diagnosis of drug resistant diagnosis of drug resistant M.tuberculosisM.tuberculosis• Biochemical tests : Biochemical tests : Catalase & Catalase &
Peroxidase Peroxidase tests tests
*** BOTH ARE NEGATIVE IN INH *** BOTH ARE NEGATIVE IN INH RESISTANT M.TUBERCULOSIS.RESISTANT M.TUBERCULOSIS.
7171
SENSITIVITY TESTSSENSITIVITY TESTS
• Absolute conc. Method : Absolute conc. Method : No.of media No.of media containing serial conc. Of the drugs are containing serial conc. Of the drugs are inoculated & minimum inhibitory inoculated & minimum inhibitory conc.calculated.conc.calculated.
• Resistance Ratio Method : Resistance Ratio Method : Two sets of Two sets of media containing graded conc.of drugs media containing graded conc.of drugs inoculated. One with test strain & other inoculated. One with test strain & other with standard strain of known sensitivity.with standard strain of known sensitivity.
• Proportion Method : Proportion Method : Average sensitivity of Average sensitivity of the strain.the strain.
7272
Various Mycobacterial gene Various Mycobacterial gene mutations involved in drug mutations involved in drug
resistance.resistance.
• rpoB gene mutation --- rpoB gene mutation --- RifampicinRifampicin
• katG & inhA mutation --- katG & inhA mutation --- INHINH
• rpsL gene mutation --- rpsL gene mutation --- StreptomycinStreptomycin
• pncA gene mutation --- pncA gene mutation --- PyrazinamidePyrazinamide
• embB gene mutation --- embB gene mutation --- EthambutolEthambutol
7373
Molecular diagnostic methods Molecular diagnostic methods for drug resistant for drug resistant
M.tuberculosisM.tuberculosis
• DNA Sequencing : DNA Sequencing : reliable & accurate.reliable & accurate.
• Line Probe Assay (LiPA) : Line Probe Assay (LiPA) : to identify mutations in the to identify mutations in the rpoB core gene.rpoB core gene.
• DNA microarrays :DNA microarrays : based on principle of hybridization based on principle of hybridization
• Molecular beacons :Molecular beacons :they are hair-pin shaped probes to they are hair-pin shaped probes to detect presence of specific nucleic acids.detect presence of specific nucleic acids.
• Single strand conformation polymorphism :Single strand conformation polymorphism :determines determines presence of mutations in specific DNA regionspresence of mutations in specific DNA regions
• FRET ( Fluorescent resonance energy transfer) probes: FRET ( Fluorescent resonance energy transfer) probes: used to detect presence of mutations in real time PCR.used to detect presence of mutations in real time PCR.
7474
Other PCR based tests:Other PCR based tests:• Amplification Refractory Mutation Amplification Refractory Mutation
System: System: has been applied to know has been applied to know mutations in rpoB, katG, embB, genes.mutations in rpoB, katG, embB, genes.
• Branch Migration Branch Migration Inhibition :Inhibition :spontaneous strand spontaneous strand exchange is inhibited by sequence exchange is inhibited by sequence difference between two DNA molecules.difference between two DNA molecules.
7575
Diagnosis of drug resistance Diagnosis of drug resistance with Mycobacteriophageswith Mycobacteriophages
• Phage amplified biological assay Phage amplified biological assay (phaB)(phaB)
• Luciferase reporter phages (LRPs)Luciferase reporter phages (LRPs)
7676
Antituberculosis Drugs Antituberculosis Drugs Currently in UseCurrently in Use
• First-line DrugsFirst-line Drugs– IsoniazidIsoniazid– RifampinRifampin– RifapentineRifapentine– RifabutinRifabutin– EthambutolEthambutol– PyrazinamidePyrazinamide
• Second-line DrugsSecond-line Drugs– CycloserineCycloserine– EthionamideEthionamide– LevofloxacinLevofloxacin– MoxifloxacinMoxifloxacin– GatifloxacinGatifloxacin– PP-Aminosalicylic acid-Aminosalicylic acid– StreptomycinStreptomycin– Amikacin/kanamycinAmikacin/kanamycin– CapreomycinCapreomycin– LinezolidLinezolid
7777
• -BCG-BCG
PREVENTION CHALLENGESPREVENTION CHALLENGES
WHO Jan 07
“BCG vaccine should not be used in children
known to be
HIV-infected”
7878